Mentice AB
STO:MNTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Mentice AB
Cash from Financing Activities
Mentice AB
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mentice AB
STO:MNTC
|
Cash from Financing Activities
kr19.7m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
RaySearch Laboratories AB (publ)
STO:RAY B
|
Cash from Financing Activities
-kr179.6m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
ContextVision AB
OSE:CONTX
|
Cash from Financing Activities
-kr5.3m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
O
|
Ortivus AB
STO:ORTI B
|
Cash from Financing Activities
kr36.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sectra AB
STO:SECT B
|
Cash from Financing Activities
-kr448.5m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-12%
|
|
|
i
|
iZafe Group AB
STO:IZAFE B
|
Cash from Financing Activities
kr11.9m
|
CAGR 3-Years
20%
|
CAGR 5-Years
82%
|
CAGR 10-Years
22%
|
|
Mentice AB
Glance View
Mentice AB provides software and hardware simulation solutions for endovascular therapies. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2019-06-18. The company provides software and hardware simulation solutions and related services for endovascular therapies. The Company’s solutions help healthcare professionals acquire, retain, and enhance their procedural skills. The Company’s solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. The firm also covers neurovascular, cardiovascular and peripheral interventions, among others. The company is active globally.
See Also
What is Mentice AB's Cash from Financing Activities?
Cash from Financing Activities
19.7m
SEK
Based on the financial report for Dec 31, 2025, Mentice AB's Cash from Financing Activities amounts to 19.7m SEK.
What is Mentice AB's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-26%
The average annual Cash from Financing Activities growth rates for Mentice AB have been -26% over the past three years .
